Wells Fargo & Company Centogene N.V. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Centogene N.V. stock. As of the latest transaction made, Wells Fargo & Company holds 197,150 shares of CNTG stock, worth $21,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
197,150
Previous 197,150
-0.0%
Holding current value
$21,686
Previous $139,000
46.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CNTG
# of Institutions
14Shares Held
472KCall Options Held
0Put Options Held
0-
Landscape Capital Management, L.L.C.164KShares$18,0740.01% of portfolio
-
Stifel Financial Corp St. Louis, MO22.5KShares$2,4690.0% of portfolio
-
Xtx Topco LTD London, X018.8KShares$2,0680.0% of portfolio
-
Black Rock Inc. New York, NY18.3KShares$2,0120.0% of portfolio
-
Barclays PLC London, X015.3KShares$1,6880.0% of portfolio
About Centogene N.V.
- Ticker CNTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,081,600
- Market Cap $2.98M
- Description
- Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...